Skip to main content
Signal8
Launch Terminal
ADAMS JULIAN profile photo

Julian Adams

CIK: 0001230486

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Elicio Therapeutics, Inc. logo
ELTX

Elicio Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Elicio Therapeutics, Inc. logo
    ELTX

    Elicio Therapeutics, Inc.

    Aug 31, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    21.8K shares-
  • Elicio Therapeutics, Inc. logo
    ELTX

    Elicio Therapeutics, Inc.

    May 19, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    7.9K shares-
  • Elicio Therapeutics, Inc. logo
    ELTX

    Elicio Therapeutics, Inc.

    Nov 21, 2024
    Award(A)

    Stock Option (Right to Buy)

    Direct
    4.1K shares-

1-3 of 3

About ADAMS JULIAN

ADAMS JULIAN (SEC CIK 0001230486) files insider reports with the SEC as Director of Elicio Therapeutics, Inc. (ELTX).

Signal8 holds 3 ownership filings by ADAMS JULIAN, all Form 4s, filed between Nov 25, 2024 and Sep 2, 2026. Those filings report 3 transactions, from Nov 21, 2024 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ADAMS JULIAN's filings is in BOSTON, MA.

Recent filings by ADAMS JULIAN

  • Aug 31, 2026: Grant or award of ELTX derivative securities (Form 4, code A).
  • May 19, 2025: Grant or award of ELTX derivative securities (Form 4, code A).
  • Nov 21, 2024: Grant or award of ELTX derivative securities (Form 4, code A).

Other insiders filing for Elicio Therapeutics, Inc. (ELTX)

How to read Form 4 transaction codes